Gliadin-Induced Ex Vivo T-Cell Response in Dermatitis Herpetiformis: A Predictor of Clinical Relapse on Gluten Challenge?

J Invest Dermatol. 2020 Sep;140(9):1867-1869.e2. doi: 10.1016/j.jid.2019.12.038. Epub 2020 Feb 7.
No abstract available

Publication types

  • Letter
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Celiac Disease / blood
  • Celiac Disease / diagnosis*
  • Celiac Disease / diet therapy
  • Celiac Disease / immunology
  • Dermatitis Herpetiformis / blood
  • Dermatitis Herpetiformis / diagnosis*
  • Dermatitis Herpetiformis / diet therapy
  • Dermatitis Herpetiformis / immunology
  • Diet, Gluten-Free
  • Enzyme-Linked Immunospot Assay / methods*
  • Feasibility Studies
  • Female
  • Gliadin / immunology
  • Glutens / administration & dosage
  • Glutens / immunology
  • Humans
  • Interferon-gamma Release Tests / methods*
  • Male
  • Middle Aged
  • Prognosis
  • Recurrence
  • T-Lymphocytes / immunology*

Substances

  • Glutens
  • Gliadin